Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

D
Dürig, Thomas

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Thomas Dürig
Favorite
Dachineni, Rakesh

Teva Branded Pharmaceutical Products R&D, Inc.
(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility
Rakesh Dachineni
Favorite
Dagher, Fatima

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Fatima Dagher
Favorite
Dai, Haiting

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Haiting Dai
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Haiting Dai
Favorite
Dalton, Caleb

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Caleb Dalton
Favorite
Damle, Shantanu

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Shantanu Damle
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Shantanu Damle
Favorite
Damm, Michael

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Michael Damm
Favorite
Dandamudi, Suman

US Food and Drug Administration
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Suman Dandamudi
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Suman Dandamudi
Favorite
Danielak, Dorota

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Dorota Danielak
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Dorota Danielak
Favorite
Daniels, Austin

Yokogawa Fluid Imaging Technologies
(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies
Austin Daniels
Favorite
Dan, Nirnoy

University of Connecticut
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Nirnoy Dan
Favorite
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Nirnoy Dan
Favorite
Dao, Huy

University of Texas at Austin
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Huy Dao
Favorite
Daram, Apoorva

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Apoorva Daram
Favorite
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Apoorva Daram
Favorite
D'Arcy, Deirdre M

Trinity College Dublin
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Deirdre M D'Arcy
Favorite
Darji, Mittal

University of Connecticut
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Mittal Darji
Favorite
Darmohusodo, Vincent

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Vincent Darmohusodo
Favorite
Darna, Mahesh

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Mahesh Darna
Favorite
Darwesh, Alaa

University of Mississippi
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Alaa Darwesh
Favorite
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Alaa Darwesh
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Alaa Darwesh
Favorite
Das, Ashish

University of Nebraska Medical Center
(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)
Ashish Das
Favorite
Das, Deb

Bayer Consumer Care
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Deb Das
Favorite
(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Deb Das
Favorite
Das, Debanjan

Bayer USA
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Debanjan Das
Favorite
(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Debanjan Das
Favorite
Dash, Alekha

Creighton University
(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
Alekha Dash
Favorite
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Alekha Dash
Favorite
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Alekha Dash
Favorite
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Alekha Dash
Favorite
Das, Hiramoy

Texas Tech University
(W0930-04-20) Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Hiramoy Das
Favorite
Das, Nandita

Butler University
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Nandita Das
Favorite
Das, Sudip

Butler University, College of Pharmacy & Health Sciences
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Sudip Das
Favorite
Date, Abhijit A.

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Abhijit A. Date
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Abhijit A. Date
Favorite
Datta- Mannan, Amita

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Amita Datta- Mannan
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Amita Datta- Mannan
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Amita Datta- Mannan
Favorite
Datta, Manu

PharmaPro Consulting
(T1230-02-12) Gaps in Non-Binary Populations in Clinical Trial Participation: A Comparative Analysis of Cardiovascular and Solid Tumor Studies
Manu Datta
Favorite
Datta, Sayantap

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Sayantap Datta
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Sayantap Datta
Favorite
Dauphin-Chanard, Elise

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Elise Dauphin-Chanard
Favorite
Dave, Rajesh

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Rajesh Dave
Favorite
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Rajesh Dave
Favorite
Dave, Shivani Amarbhai

Massachusetts College of Pharmacy and Health Sciences
(W1230-09-50) Preparation and Characterization of an Ultraflexible Liposomal Gel for Transdermal Delivery of a Novel Pan-RAS Inhibitor for Melanoma
Shivani Amarbhai Dave
Favorite
Dave, Vivek

St. John's University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Vivek Dave
Favorite
Davies, Brandon

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brandon Davies
Favorite
Davies, Daryl L.

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Daryl L. Davies
Favorite
Davies, Neal

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Neal Davies
Favorite
(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products
Neal Davies
Favorite
Davis, Daniel

AustinPx
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Daniel Davis
Favorite
Daware, Snehal

St. John's University
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Snehal Daware
Favorite
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Snehal Daware
Favorite
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Snehal Daware
Favorite
Daware, Snehal

St. John's University
(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity
Snehal Daware
Favorite
De Borba, Brian

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Brian De Borba
Favorite
De Coninck, Elien

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Elien De Coninck
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Elien De Coninck
Favorite
De Leon Ortega, Ricardo Diaz

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Ricardo Diaz De Leon Ortega
Favorite
de Margerie, Victoire

Rondol Industrie
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Victoire de Margerie
Favorite
De Mario, Deidre

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Deidre De Mario
Favorite
De Paiva, Igor

AstraZeneca
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Igor De Paiva
Favorite
De Smedt, Frank

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Frank De Smedt
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Frank De Smedt
Favorite
De Smet, Lieselotte

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Lieselotte De Smet
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Lieselotte De Smet
Favorite
Dean, Nicholas

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Nicholas Dean
Favorite
Dear, Barton

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Barton Dear
Favorite
Debad, Jeff

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Jeff Debad
Favorite
Debies, Michael

Medpace
(W1030-02-07) Determination of the Concentration of Monoclonal Antibodies (Mab) Drug in Human Serum Using an Enzyme-Linked Immunosorbent Assay (ELISA)
Michael Debies
Favorite
Debnath, Sujit

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Sujit Debnath
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Sujit Debnath
Favorite
Deb, Sarmistha

DiponED Biointelligence
(M1130-02-07) The Significance of Biotransformation in Discovery Research of NCEs (New Chemical Entity): Examples of Unique Case Studies
Sarmistha Deb
Favorite
Debunne, Ann

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Ann Debunne
Favorite
DelCarpini, Jason

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Jason DelCarpini
Favorite
Delebecq, Sandra

Aliri Bioanalysis
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Sandra Delebecq
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Sandra Delebecq
Favorite
Delgado, Dennis

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Dennis Delgado
Favorite
Dellaripa, Michael

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Michael Dellaripa
Favorite
Dema, Krysten

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Krysten Dema
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Krysten Dema
Favorite
Dematteis, Giorgia

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Giorgia Dematteis
Favorite
(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments
Giorgia Dematteis
Favorite
Deng, Jing

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Jing Deng
Favorite
Denis, Lucas

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Lucas Denis
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Lucas Denis
Favorite
Denninger, Alexander

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Alexander Denninger
Favorite
Dent, Alecia

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Alecia Dent
Favorite
Desai, Kashappa

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Kashappa Desai
Favorite
Desai, Mehul

Enable Injections
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Mehul Desai
Favorite
Desai, Pankaj

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Pankaj Desai
Favorite
Desai, Pooja

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Pooja Desai
Favorite
Deshmukh, Janhavi

University of Mississippi
(M1230-05-29) Employing Hot Melt Extrusion and Vacuum Compression Molding to Develop Cannabidiol Solid Sedds for Improved Solubility
Janhavi Deshmukh
Favorite
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Janhavi Deshmukh
Favorite
Deshmukh, Ketkee

Gattefosse India Pvt. Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Ketkee Deshmukh
Favorite
Desu, Hari

Intera Healthcare
(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation
Hari Desu
Favorite
Devalapally, Harikrishna

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Harikrishna Devalapally
Favorite
Develin, Corey

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Corey Develin
Favorite
Deveney, Katherine

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Katherine Deveney
Favorite
Dev, Satyanarayan

Florida A&M University
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Satyanarayan Dev
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Satyanarayan Dev
Favorite
Dey Chowdhury, Sumana

Nova Southereastern University
(M0930-07-38) Evaluating Mucoadhesion of Polymer Films Using Wax Substrates with Mucin Coating
Sumana Dey Chowdhury
Favorite
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Sumana Dey Chowdhury
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Sumana Dey Chowdhury
Favorite
Dey, Anuradha

Mercer University
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Anuradha Dey
Favorite
Dhawan, Punita

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Punita Dhawan
Favorite
Dhawan, Vivek

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Vivek Dhawan
Favorite
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Vivek Dhawan
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Vivek Dhawan
Favorite
Dholariya, Bhoomi

St. John's University
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Bhoomi Dholariya
Favorite
Dhungana, Suraj

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Suraj Dhungana
Favorite
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Suraj Dhungana
Favorite
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Suraj Dhungana
Favorite
Di Gallo, Nicole

Merck Life Science KGaA
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Nicole Di Gallo
Favorite
Diao, Jianbo

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Jianbo Diao
Favorite
Dias, Camila

State University of Campinas
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Camila Dias
Favorite
DiazDavila, Karelys

Palm Beach Atlantic University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Karelys DiazDavila
Favorite
Diaz, Patricia

University of Buffalo
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Patricia Diaz
Favorite
DiBlasi, Robert

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Robert DiBlasi
Favorite
Diep, Anh

23andMe Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Anh Diep
Favorite
Dietrich, Shirin

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Shirin Dietrich
Favorite
Digby, Matthew

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Matthew Digby
Favorite
Digigow, Reinaldo

CSL Vifor
(T1430-02-07) Exploring the Potential Influence of Physicochemical Characteristics on Biodistribution of Iron-Carbohydrate Nanoparticles Using a Chicken Embryo Model
Reinaldo Digigow
Favorite
Diluzio, Willow

Sarepta Therapeutics
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Willow Diluzio
Favorite
Dimen, Rain

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Rain Dimen
Favorite
Dinge, Aditya

Bayer AG
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Aditya Dinge
Favorite
Ding, Kai

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Kai Ding
Favorite
Ding, Ling

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Ling Ding
Favorite
Ding, Tao

US Food and Drug Administration
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Tao Ding
Favorite
Ding, Wenping

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Wenping Ding
Favorite
Ding, Xiaoyi

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Xiaoyi Ding
Favorite
Dinh, Jean

Certara Predictive Technologies
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Jean Dinh
Favorite
Diogo, Joana

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Joana Diogo
Favorite
Diorio, Alec

St. John's University
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Alec Diorio
Favorite
Ditschun, Tanya

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Tanya Ditschun
Favorite
Diwan, Rimpy

University of Michigan
(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes
Rimpy Diwan
Favorite
Dixon-Anderson, Erik

Roquette America Inc.
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Erik Dixon-Anderson
Favorite
Djehizian, Alexandre

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Alexandre Djehizian
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Alexandre Djehizian
Favorite
D'mello, Anil

St. Joseph's University
(T1430-04-24) Method Optimization to Reduce Leakage of Encapsulated Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as a Model Protein
Anil D'mello
Favorite
Dobariya, Gunvant

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Gunvant Dobariya
Favorite
Do, Bernard

Gustave Roussy Cancer Campus
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Bernard Do
Favorite
Dobosz, Justyna

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Justyna Dobosz
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Justyna Dobosz
Favorite
Dobrovolskaia, Marina

National Cancer Institute
(W1030-02-11) Immunotoxicity of Silica Nanoparticles as a Function of Physicochemical Properties
Marina Dobrovolskaia
Favorite
Dogra, Prashant

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Prashant Dogra
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Prashant Dogra
Favorite
Doluisioa, Nicholas

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Nicholas Doluisioa
Favorite
Domanski, Brian

Shimadzu Scientific Instruments, Inc.
(T1530-06-34) Ion-pairing Agent-Free SFC Separation of Polypeptides Using Automated Method Development Tools
Brian Domanski
Favorite
Donaldson, Douglas

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Douglas Donaldson
Favorite
Donaldson, Kirsteen

Jade Consultants (Cambridge) Limited
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Kirsteen Donaldson
Favorite
Dongala, Bhanu Prakash

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Bhanu Prakash Dongala
Favorite
Dong, Lynn

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Lynn Dong
Favorite
Dong, Quyen

Merck Sharp & Dohme Corp.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Quyen Dong
Favorite
Dong, Tao

University of California San Diego
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Tao Dong
Favorite
Dong, Yuxiang

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Yuxiang Dong
Favorite
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Yuxiang Dong
Favorite
Donnelly, Ryan

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Ryan Donnelly
Favorite
(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide
Ryan Donnelly
Favorite
(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants
Ryan Donnelly
Favorite
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Ryan Donnelly
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Ryan Donnelly
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Ryan Donnelly
Favorite
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Ryan Donnelly
Favorite
(W0930-02-07) Revolutionising Microneedle-Based Transdermal Delivery: A Colourful Approach to Efficiency Feedback and User Navigation
Ryan Donnelly
Favorite
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Ryan Donnelly
Favorite
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Ryan Donnelly
Favorite
Donovan, Maureen

University of Iowa
(M1130-03-18) Model-Informed Approach for Formulation Development of Extended-Release Phenserine Tablets to Mitigate pH-Dependent Degradation
Maureen Donovan
Favorite
Don, Ranganath Wahalathantrige

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Ranganath Wahalathantrige Don
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Ranganath Wahalathantrige Don
Favorite
Doole, Fathima

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Fathima Doole
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Fathima Doole
Favorite
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Fathima Doole
Favorite
Doran, Delaney

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Delaney Doran
Favorite
Doran, Jake

University of Pittsburgh
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Jake Doran
Favorite
Dorfman, Ryan

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Ryan Dorfman
Favorite
Doroski, Todd

Alcami Corporation
(M1330-04-24) High-Performance Liquid Chromatography Method with Refractive-Index Detection for Quantitation of Memantine Hydrochloride in Memantine Hydrochloride Extended-Release Dissolution Samples
Todd Doroski
Favorite
Dos Santos, Erica

Unicamp
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Erica Dos Santos
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Erica Dos Santos
Favorite
Dow, Alex

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Alex Dow
Favorite
Dowek, Antoine

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Antoine Dowek
Favorite
Downey, Andrew

Bill & Melinda Gates Medical Research Institute
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Andrew Downey
Favorite
Dow, Ximeng

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Ximeng Dow
Favorite
Doyle, Jailen

University of Texas at Austin
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Jailen Doyle
Favorite
Dreibelbis, Mark

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Mark Dreibelbis
Favorite
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Mark Dreibelbis
Favorite
Drelich, Aleksandra

University of Texas Medical Branch
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Aleksandra Drelich
Favorite
Drennen, James K.

Duquesne University
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
James K. Drennen
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
James K. Drennen
Favorite
D'Souza, Arun

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Arun D'Souza
Favorite
D'Souza, Marissa

University of Michigan
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Marissa D'Souza
Favorite
D'Souza, Martin

Mercer University
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Martin D'Souza
Favorite
D'Souza, Martin J.

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Martin J. D'Souza
Favorite
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Martin J. D'Souza
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Martin J. D'Souza
Favorite
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Martin J. D'Souza
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Martin J. D'Souza
Favorite
Dube, Gabriella

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Gabriella Dube
Favorite
Dube, Maricar

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Maricar Dube
Favorite
Dubey, Kiran

Jamia Hamdard University
(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment
Kiran Dubey
Favorite
Ducros, Malaury

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Malaury Ducros
Favorite
Dudhipala, Narendar

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Narendar Dudhipala
Favorite
Duffy, Patrick

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Patrick Duffy
Favorite
Dugas, Helene

Dow Chemical Company
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Helene Dugas
Favorite
Duggirala, Naga Kiran

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Naga Kiran Duggirala
Favorite
Duhamel, Paul

Aliri Bioanalysis
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Paul Duhamel
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Paul Duhamel
Favorite
Dukaj, Suada

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Suada Dukaj
Favorite
Dukes, Kyle

Biotage LLC
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Kyle Dukes
Favorite
Dukhande, Vikas

St. John's University
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Vikas Dukhande
Favorite
Dumpa, Nagireddy

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Nagireddy Dumpa
Favorite
Dunn, Gabrielle

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Gabrielle Dunn
Favorite
Duong, Tu

Purdue University
(M1330-07-38) Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance
Tu Duong
Favorite
Duran, Tibo

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Tibo Duran
Favorite
Durig, Thomas

Ashland Life Sciences
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Thomas Durig
Favorite
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Thomas Durig
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Thomas Durig
Favorite
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Thomas Durig
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Thomas Durig
Favorite
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Thomas Durig
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Thomas Durig
Favorite
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Thomas Durig
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Thomas Durig
Favorite
DuRoss, Allison

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Allison DuRoss
Favorite
Durve, Sanjana

St. John's University
(W1130-04-20) A Nano-Emulsion-Based Formulation of Sorafenib for Oral Bioavailability Enhancement and Repurposing against Non-small Cell Lung Cancer (NSCLC)
Sanjana Durve
Favorite
Dusane, Apurva

University of Iowa
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Apurva Dusane
Favorite
Du, Xiangsha

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Xiangsha Du
Favorite
Du, Xiaoqing

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Xiaoqing Du
Favorite
Dwivedi, Pankaj

University of Health Science and Pharmacy in Saint Louis
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Pankaj Dwivedi
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Pankaj Dwivedi
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Pankaj Dwivedi
Favorite
Dwivedi, Subash

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Subash Dwivedi
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Subash Dwivedi
Favorite
Dysinger, Mark

Alexion Pharmaceuticals, Inc.
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Mark Dysinger
Favorite